Visikol, Inc.

New Brunswick, NJ · Medtech · Still private

Optical CT imaging device and automated machine learning software for quantitative skeletal defect detection in developmental toxicology studies

Claim this profile

Follows are private to you and power your alerts

Updated Oct 23, 2026 · visikol.com

Sector: Medtech
Headquarters: New Brunswick, NJ
Total capital: $3.3M

Federal grants: $3.3M; 8 awards · 2016–2022; Rank in peer group#266 of 538
Private capital raised: None on recordNo Form D filings on SEC EDGAR. Some raises are not filed.
Federal contracts: None on recordNo federal contract awards found.
Granted patents: 0; 6 pending

Capital timeline

Latest events

May 2022Federal grantHealth and Human S · Phase II · Development of a 3D Imaging Diagnostic Tool for the Improved Characterization of Metastatic Melanoma$785K
Apr 2021Federal grantHealth and Human S · Phase II · Development of a 3D Imaging Diagnostic Tool for the Improved Characterization of Metastatic Melanoma$844K
Apr 2019Federal grantNSF · Phase II · SBIR Phase II: Digitization of Skeletal Evaluations for Developmental and Reproductive Toxicology (DART) Studies.$750K
Feb 2019Federal grantHealth and Human S · Phase I · Development of a High-Throughput Three-Dimensional H&E Platform for the Characterization of Breast Cancer Biopsies$55K
Aug 2018Federal grantHealth and Human S · Phase I · Improved Characterization of 3D In Vitro Cell Culture Assays for the Drug Discovery Process$225K
Apr 2018Federal grantHealth and Human S · Phase I · Development of a High-Throughput Three-Dimensional H&E Platform for the Characterization of Breast Cancer Biopsies$225K
Jan 2018Federal grantNSF · Phase I · SBIR Phase I: Digitization of Skeletal Evaluations for Developmental and Reproductive Toxicology (DART) Studies.$225K

Show 1 earlier federal award

Jul 2016Federal grantNSF · Phase I · SBIR Phase I: Improved Skeletal Visualization Technology for Developmental and Reproductive Toxicology (DART) Studies$225K

Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.

Standing among 538 peers

Line = median

Medtech · Device

Federal grants#266 · top 49%

Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.

Founders and team

No founders are linked to this company yet.

Founders appear once a person is matched to the company through its own patents, grants or filings. We never infer people from social profiles.

Checked: USPTO inventors; federal award principal investigators; SEC Form D related persons · Oct 23, 2026

Claim this profile to add your team

What it has protected

USPTO · 0 granted of 6

Dec 9, 2021PendingDetection Of Biologicals Penetration Into Tissue SurrogatesUSPTOApplication 17288060
Jan 25, 2018PendingMethod For Visualization Of Calcium Containing Components In Biological SystemsUSPTOApplication 15659372
PendingDetection Of Biologicals Penetration Into Tissue SurrogatesUSPTOApplication PCTUS2018052796

Show all 6 patent records

Detection Of Biologicals Penetration Into Tissue SurrogatesDec 9, 2021 · Application 17288060Pending
Method For Visualization Of Calcium Containing Components In Biological SystemsJan 25, 2018 · Application 15659372Pending
Detection Of Biologicals Penetration Into Tissue SurrogatesApplication PCTUS2018052796Pending
Method For Visualization Of 3-D Tissue CulturesApplication PCTUS2018018730Pending
Method For Visualization Of Calcium-containing Components In Biological SystemsApplication PCTUS2017043764Pending
Method For Visualization Of Calcium-containing Components In Biological SystemsApplication 62366238Pending

Z-QUICK, LLCSimilar federal contract value in Medtech · null in contracts
ENGINEERING RESOURCES GROUP INCSimilar federal contract value in Medtech · null in contracts
GLYCIOME, LLCSimilar federal contract value in Medtech · null in contracts
POLYAURUM, LLCSimilar federal contract value in Medtech · null in contracts
M2-COR, INC.Similar federal contract value in Medtech · null in contracts
BIORESP TECHNOLOGIES, INC.Similar federal contract value in Medtech · null in contracts

Regulatory activity · Medtech

Sector-level, not company-level

07 Jul 2026New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
30 Jun 2026Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
30 Jun 2026Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
29 Jun 2026Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
26 Jun 2026Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
26 Jun 2026Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.

Sources

Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.

How to read this page

Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.

Data freshness

SEC Form D filings through Oct 23, 2026. SBIR and STTR awards through Oct 21, 2026.